XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Public offering
At-The-Market Offering
PREFERRED STOCK
COMMON STOCK
COMMON STOCK
Public offering
COMMON STOCK
At-The-Market Offering
ADDITIONAL PAID-IN CAPITAL
ADDITIONAL PAID-IN CAPITAL
Public offering
ADDITIONAL PAID-IN CAPITAL
At-The-Market Offering
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE INCOME / (LOSS)
Beginning balance (in shares) at Dec. 31, 2020       0                
Beginning balance (in shares) at Dec. 31, 2020         8,506,651              
Beginning balance at Dec. 31, 2020 $ 34,170       $ 1     $ 371,518     $ (337,406) $ 57
Increase (Decrease) in Shareholders' Equity                        
Net Loss (32,674)                   (32,674)  
Unrealized Loss on Available-for-Sale Investments (6)                     (6)
Foreign Currency Translation Adjustments 1                     1
Vesting of Restricted Stock Units Issued, net of taxes withheld (in shares)         23,483              
Vesting of Restricted Stock Units Issued, net of taxes withheld (6)             (6)        
Warrant Modification Expense 107             107        
Stock-based Compensation $ 943             943        
Ending balance (in shares) at Dec. 31, 2021 0     0                
Ending balance (in shares) at Dec. 31, 2021 8,544,225       8,544,225              
Ending balance at Dec. 31, 2021 $ 2,535       $ 1     372,562     (370,080) 52
Increase (Decrease) in Shareholders' Equity                        
Net Loss (18,679)                   (18,679)  
Unrealized Loss on Available-for-Sale Investments 114                     114
Foreign Currency Translation Adjustments (3)                     (3)
Vesting of Restricted Stock Units Issued, net of taxes withheld (in shares)         10,958              
Vesting of Restricted Stock Units Issued, net of taxes withheld $ 0                      
Warrant Modification Expense (in shares) 14,091                      
Issuance of stock, net of offering costs (in shares)       15,000   844,613 7,500          
Issuance of stock, net of offering costs $ 14,916 $ 14,893 $ 15         14,916 $ 14,893 $ 15    
Issuance of common stock upon exercise of prefunded warrants (in shares)         2,756,377              
Stock-based Compensation $ 315             315        
Ending balance (in shares) at Dec. 31, 2022 15,000     15,000                
Ending balance (in shares) at Dec. 31, 2022 12,163,673       12,163,673              
Ending balance at Dec. 31, 2022 $ 14,106       $ 1     $ 402,701     $ (388,759) $ 163